Eliem Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.313; its P/E ratio is -3.37; Eliem Therapeutics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -3.97M	$ -5.16M	$ -22.03M	$ -7.54M	$ -8.75M
EBITDA	$ -3.97M	$ -5.90M	$ -22.52M	$ -7.94M	$ -8.75M
Net Income Common Stockholders	$ -3.97M	$ -5.22M	$ -22.03M	$ -7.54M	$ -9.68M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 107.43M	$ 102.63M	$ 109.37M	$ 123.57M	$ 122.62M
Total Assets	$ 112.73M	$ 116.27M	$ 122.08M	$ 134.99M	$ 140.86M
Total Debt	$ 459.00K	$ 585.00K	$ 687.00K	$ 480.00K	$ 571.00K
Net Debt	$ -106.97M	$ -102.05M	$ -108.69M	$ -123.09M	$ -122.05M
Total Liabilities	$ 2.99M	$ 3.77M	$ 5.22M	$ 6.28M	$ 6.50M
Stockholders Equity	$ 109.74M	$ 112.47M	$ 116.81M	$ 128.72M	$ 134.36M
Cash Flow	-
Free Cash Flow	$ 3.49M	$ -7.96M	$ -15.18M	$ -8.45M	$ -4.17M
Operating Cash Flow	$ 3.49M	$ -7.96M	$ -15.18M	$ -8.45M	$ -4.17M
Investing Cash Flow	$ 28.04M	$ -1.60M	$ 5.80M	$ 14.28M	$ 8.51M
Financing Cash Flow	$ 528.00K	$ 24.00K	$ 1.00K	-	$ 0.00

Currency in USD

Eliem Therapeutics Earnings and Revenue History

Income Statement >

Eliem Therapeutics Debt to Assets

Balance Sheet >

Eliem Therapeutics Cash Flow

Cash Flow >

Eliem Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing